Neurophet to unveil new technology for analyzing ARIA side effect at ECR 2023
- Written by PR Newswire
![]() |
- Introducing brain imaging analysis solutions including Neurophet AQUA and Neurophet SCALE PET
- Unveiling technology to analyze and monitor ARIA, side effect of anti-amyloid antibody drug for Alzheimer's disease
SEOUL, South Korea, March 2, 2023 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease,...
Read more: Neurophet to unveil new technology for analyzing ARIA side effect at ECR 2023